Christopher Paul O�Regan
Health Technology Assessment and Outcomes Research, UK
Dr. Christopher is Head of Health Technology Assessment and Outcomes Research at MSD (UK) since February 2009. Employed to lead the newly incorporated group of nine EBM, HTA and OR personnel and establish the team′s role in identification and provision of country needs into PIII trial design, pricing and re-imbursement, as well as the delivery of HTA submissions to the devolved national entities (NICE, SMC & AWMSG) and NCPE in Ireland.
